Kestra Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History

Kestra Advisory Services’s Portfolio NBIX Stock Details NBIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$52.9K	Buy
2024 Q3	–	Sell
2024 Q2	$237K	Buy
2024 Q1	$235K	Buy
2023 Q1	–	Sell
2022 Q4	$380K	Buy